Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Medicover Neuroendokrinologie MVZ

Research site

Germany Orleansplatz 3, 81667 Munich, Germany

  • Type 2 diabetes mellitus
  • Adult patients

About Specializations

Medicover Neuroendokrinologie MVZ in Munich, Germany specialises in clinical trials of conditions such as Type 2 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases

The Medicover Neuroendokrinologie MVZ conducts clinical research on type 2 diabetes, seeking to enhance blood‑sugar regulation and support weight management for patients with metabolic challenges.

  • Evaluation of new peptide‑based therapies for glycaemic control
  • Comparison of treatment outcomes in individuals on metformin with or without SGLT2 inhibitors
  • Measurement of changes in HbA1c and body weight as primary effectiveness indicators

The studies aim to expand therapeutic options and improve long‑term health prospects for those living with metabolic disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Orleansplatz 381667 MunichGermany
Open in maps ↗
Recruiting now
no trials
Conditions studied
1

More sites in MunichGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Type 2 diabetes mellitus

Not recruiting

Study comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus

Not recruiting

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.